In-Vitro Bioequivalence Study of Bile Acid Sequestrants by HPCL

Veure altres versions (1)

Guardat en:

Dades bibliogràfiques
Autor principal:	Raina Sunny
Format:	Thesis Llibre
Idioma:	anglès
Publicat:	Mumbai NMIMS 2020
Matèries:	Bile acid > Bioequivalence > Bioanalytical Method
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

IN-VITRO BIOEQUIVALENCE STUDY OF BILE ACID SEQUESTRANTS BY HPCL
per: RAINA,SUNNY
Publicat: (2020)

Pharmaceutical bioequivalence
per: Welling,Peter G
Publicat: (2010)

Method Development, Validation and In-Vivo Bioequivalence Studies
per: Shaikh Khurshid Alam Quamaruddin
Publicat: (2022)

ACID RAIN
per: LUCAS EILEEN
Publicat: (1991)

Acid Attack and Victim Compensation Scheme.
per: SINGH, GYANENDRA PRATAP
Publicat: (2014)

TESTING THE POTENTIAL OF A STRESS RESITANT STRAIN OF E. COLI AS A CHASSIS FOR FATTY ACID SYNTHESIS
per: NEHA RAJIV SAWANT
Publicat: (2019)

Symposium and phaedrues
per: Plato
Publicat: (1993)

Method Development, Validation and In-Vivo Bioequivalence Studies of Anti-Diabetic Drugs
per: Wattamwar Tejas Baboo
Publicat: (2021)

SYNTHESIS, CHARACTERIZATION, ENGINE PERFORMANCE AND EMISSION AND COLD FLOW PROPERTY ENHANCEMENT OF PONGAMIA PINNATAOIL BASED FATTY ACID METHYL ESTER (FAME)
per: NANCY SONI J.
Publicat: (2019)

Exploring Interplay: Serum uric Acid Levels And Key Metabolic Biomarkers In Type -2 Diabetes Patients
per: Sen,Devanshi Rakesh
Publicat: (2024)

HPCL FOR PHARMACEUTICAL SCIENTISTS
per: KAZAKEVICH YURI
Publicat: (2007)

HPCL: Customer Service Initiatives
per: Satya Srinivas Srikanti,under the direction of S.V.Rama Kris
Publicat: (2005)

Assess the potential anti-viral activity of rosamarinic acid and leutin against 4 serotypes of dengue virus
per: Panchal,Ritesh
Publicat: (2023)

Development of Validated Stability-Indicating HPCL Method of Certain Drugs with Identification of Impurities Using LC- MS
per: Joshi, Payal B.
Publicat: (2010)

In vitro fertilization
per: Elder, K
Publicat: (2011)

IN-VITRO EVALUATION OF HEPATIC AND EXTRA-HEPATIC METABOLISM OF POLYPHENOLS (GALLIC ACID AND TANNIC ACID) BY USING SUBCEL
per: PHATAK VAIDEHI

Acid
per: Sreenivasan, Sangeetha
Publicat: (2018)

PHARMACEUTICAL BIOEQUIVALENCE
per: WELLING PETER G
Publicat: (2006)

PHARMACEUTICAL BIOEQUIVALENCE
per: WELLING PETER [E], TSE FRANCIS L [E], DIGHE SHRIKANT V [E]
Publicat: (2006)

BIOAVAILABILITY AND BIOEQUIVALENCE IN...
per: PAL [A]
Publicat: (2008)

HANDBOOK OF PHARMACEUTICAL ANALYSIS BY HPCL VOL 6
per: AHUJA SATINDER
Publicat: (2005)

In vitro toxicity testing
per: SFrazier,John M
Publicat: (1992)

DESIGNE AND ANALYSIS OF BIOVAILABILITY AND BIOEQUIVALENCE STUDIES
per: CHOW SHIENCHUNG
Publicat: (2002)

DESIGN AND ANALYSIS OF BIOAVAILABILITY AND BIOEQUIVALENCE STUDIES
per: CHOW SHEIN-CHUNG
Publicat: (2000)

DESIGN AND ANALYSIS OF BIOAVAILABILITY AND BIOEQUIVALENCE STUDIES
per: CHOW S [A]
Publicat: (2000)

Acid rain
per: Lucas, Eileen
Publicat: (1991)

THE DIMER ACIDS
per: LEONARD,E C ED
Publicat: (1975)

ANALYSIS OF AMINO ACIDS, PROTEINS AND NUCLEIC ACIDS
per: BIOTOL [A]
Publicat: (2004)

HANDBOOK OF BIOEQUIVALENCE TESTING
per: NIAZI SARFARAZ K
Publicat: (2007)

Dissolution, bioavailability & bioequivalence
per: Abdou, Hamed M.
Publicat: (1989)

Dissolution,bioavailability and bioequivalence
per: Abdou,Hamed M
Publicat: (1989)

Vitro functionality of probiotics in foods
per: Mortazavian, A.
Publicat: (2021)

IN VITRO CULTIVATION OF ANIMAL CELLS
per: BIOTOL [A]
Publicat: (2004)

Polymorphism and cocrystal studies of Mefenamic acid
per: Ankita Pradeep Tare
Publicat: (2018)

BIOAVAILABILITY AND BIOEQUIVALENCE STUDY OF AMOXYCILLIN 875 MG AND CLAVULANIC ACID 125 MG TABLET UNDER FED CONDITION ON
per: TRANGADIYA NIDHI

Research methods for cultural studies
per: Pickering,Michael
Publicat: (2018)

APPLICATION OF CASE STUDY RESEARCH
per: YIN ROBERT K
Publicat: (1993)

Bioequivalence Study of Drugs: Its Facilities and Techniques
per: Pal, Bhaswati
Publicat: (2019)

Conductionof Clilical Phase in Bioavailability and Bioequivalence Study
per: Singh Abhishek Bijoy

BIOEQUIVALENCE STUDY OF GABAPENTIN CAPSULES 400 mg
per: KADAM VISHAL